|
|
|
 |
New diabetes drugIn March 2005 the FDA approved Symlin (pramlintide acetate), an injectable medicine to direction blood sugar for adults with emblem 1 and type 2 diabetes. Symlin is the single therapy for treating type 1 diabetes other than insulin. clan with type 2 diabetes already have several other emblems of oral therapies available. Symlin is to be used solitary in combination with insulin to help lower vital fluid sugar during the three hours after meals. It is meant for patients who cannot achieve adequate vital current sugar control on intensive insulin therapy alone. So-called "tight" superintendence of blood sugar is desirable in all patients with diabetes to bring the risk of blindness, kidney disease, vascular disease, and other long-term moot points that diabetes can cause. The safety and effectiveness of Symlin were studied in about 5000 tribe Side effects include nausea, vomiting, abdominal pain, headache, fatigue, and dizziness. Because of three areas of pertain to there will be a medication guide and a risk minimization action plan for the use of Symlin. First, the principal risk is hypoglycemia, an abnormally depressed concentration of sugar in the life-blood This risk is greatest in tribe with type i diabetes and clan with slow stomach emptying (gastroparesis), a long-term complication of diabetes. next to the first there is a potential for medication errors, specifically, mixing Symlin with insulin in the same syringe, which can alter the activity of the insulin. Finally, the potential for off-label use in family where the benefit-risk profile has not been characterized or demonstrated is also of relate to and will be monitored by the agency of the sponsor. Symlin has not been evaluated in children. The therapy should not be used if race cannot tell when their vital fluid sugar is low, have gastroparesis, or are allergic to pramlintide acetate, metacresol, D-mannitol, acetic acid, or sodium acetate. Symlin is manufactured by dint of Amylin Pharmaceuticals Inc. of San Diego. COPYRIGHT 2005 U rule Printing Office through publishing a new data-exchange standard, a superintendences manufacturer hopes to render certain interoperability from machine control to enterprise supply-chain applications and to accelerate the adoptio... After lengthy Silence Politeness fades, a small anchovy gleam leaving the upturn saucepan in the dishrack after the satellite has wandered out of the window. single of the... Byline: Brent Snavely Longtime local chef Jeff Baldwin is stepping without from the confines of fine dining and into the world of casual dining and carry-out. Baldwin has op... It is many times said that, to be lucky in manufacturing, you have to have a passion for it. Sometimes, however, having a passion for your customers' passion is important, too. This point became ... Because of collet adaptation tap [i]or[/i] pats three-jaw, chuck-style machines can cope with collet-style CNC lathes. stores using these special adapters reap the benefits of collet workholding. Thes... novel YORK--Peter Max will return to Artexpo this year with a busy booth He will be unveiling 30 fresh collectors-edition prints of his famous icons reproduc in miniature. The series will be avail... 00-00-0000 The 32nd annual report upon the performance of major machine-tool companies is now available from AMT. This edition provides data by the agency of rank, company, country, ma... COMMUNICATION: PAST AND near by what mode do agents deal with novel information that may be of relevance to others? by what mode do they convey their knowledge to the public? And what are the eff... The Rich and Strange Collaboration of Alfred Hitchcock and David 0 Selznick in Hollywood by dint of Leonard J. Leff. University of California Press/383 pp/$2495 (sb) The David 0 Selznick-Alfred Hit... The spiritual search either culminates in liberation or continues upon as the struggle for it. Negation can be negated in infinite ways-through kindness, end art, through self-sacrifice, through f... |
|
Articles
|
| . |